Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02576912 · ClinicalTrials.gov registry record · Phase 1

Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone

A Phase 1 study of Healthy, sponsored by Yale University.

Completed
Registry status
Phase 1
Development phase
38
Enrollment target
1
Study location

NCT02576912 is a Phase 1 study of Healthy that has completed, run by Yale University. The registered enrollment target is 38 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02576912, a Phase 1 study of Healthy, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 1
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

The overall purpose of this study is to examine the effect of pregnenolone (PREG) on the acute psychosis-like and cognitive effects of Delta-9-tetrahydrocannabinol (THC). This will be tested by pretreating healthy individuals with PREG and then assessing their responses to THC.

Conditions Studied

Healthy

Interventions

  • DRUG Placebo
  • DRUG Active Delta-9-THC
  • DRUG Active Pregnenolone

Study Locations (1)

Connecticut

  • Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine - West Haven

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2015-02
Est. Completion 2019-06-24
Phase Phase 1

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02576912

The ClinicalTrials.gov registry entry for NCT02576912 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT02576912 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT02576912 about?

NCT02576912 is a clinical study titled "Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone". The overall purpose of this study is to examine the effect of pregnenolone (PREG) on the acute psychosis-like and cognitive effects of Delta-9-tetrahydrocannabinol (THC). This will be tested by pretreating healthy individuals with PREG and then assessing their responses to THC.

What is the current status of trial NCT02576912?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2015-02. Estimated completion is 2019-06-24.

What conditions does trial NCT02576912 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02576912?

The interventions under investigation include: Placebo (DRUG), Active Delta-9-THC (DRUG), Active Pregnenolone (DRUG).

Who is sponsoring clinical trial NCT02576912?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02576912 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.